Healthy (For Part A)
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies (NCT02629692) | Sun Pharma Advanced Research Company Limited | 2016-06-27 |
Track Healthy (For Part A) automatically
Every clearance here is in the API, with alerts when new ones post.